Template:Neonatal meningitis antibiotics - Revision history

Danbot: Convert to AntibioticDose with disease=Meningitis, population=Pediatric

2026-03-20T00:57:30Z

Convert to AntibioticDose with disease=Meningitis, population=Pediatric

← Revisión anterior		Revisión del 00:57 20 mar 2026
Línea 1:		Línea 1:
	''[[MRSA]] is uncommon in the neonate		''[[MRSA]] is uncommon in the neonate
	*[[Ampicillin]] 75mg/kg IV q6hrs '''PLUS'''		*{{AntibioticDose\|disease=Meningitis\|drug=Ampicillin\|dose=75mg/kg IV q6hrs\|context=Neonatal\|population=Pediatric}} '''PLUS'''
	*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs		*{{AntibioticDose\|disease=Meningitis\|drug=Cefotaxime\|dose=50mg/kg IV q6hrs\|context=Neonatal\|population=Pediatric}} '''OR''' {{AntibioticDose\|disease=Meningitis\|drug=Gentamicin\|dose=2.5mg/kg IV q8hrs\|context=Neonatal\|population=Pediatric\|link=no}}
	**Per AAP, [[ceftazidime]] 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups<ref>https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1</ref>		**Per AAP, [[ceftazidime]] 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups<ref>https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1</ref>
	*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]		*If suspecting [[S. pneumoniae]] or [[MRSA]], add {{AntibioticDose\|disease=Meningitis\|drug=Vancomycin\|dose=standard neonatal dosing\|context=Neonatal, MRSA/Pneumococcus\|population=Pediatric\|link=no}}
	*Consider [[acyclovir]] for [[HSV]]		*Consider [[acyclovir]] for [[HSV]]

Dieseldoc at 04:37, 15 October 2021

2021-10-15T04:37:50Z

← Revisión anterior		Revisión del 04:37 15 oct 2021
Línea 1:		Línea 1:
	''[[MRSA]] is uncommon in the neonate		''[[MRSA]] is uncommon in the neonate
	*[[Ampicillin]] ~~50mg~~/kg IV q6hrs '''PLUS'''		*[[Ampicillin]] 75mg/kg IV q6hrs '''PLUS'''
	*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs		*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs
	**Per AAP, [[ceftazidime]] 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups<ref>https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1</ref>		**Per AAP, [[ceftazidime]] 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups<ref>https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1</ref>
	*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]		*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]
	*Consider [[acyclovir]] for [[HSV]]		*Consider [[acyclovir]] for [[HSV]]

ClaireLewis at 00:00, 22 October 2020

2020-10-22T00:00:46Z

← Revisión anterior		Revisión del 00:00 22 oct 2020
Línea 1:		Línea 1:
	''MRSA is uncommon in the neonate		''[[MRSA]] is uncommon in the neonate
	*[[Ampicillin]] 50mg/kg IV q6hrs '''PLUS'''		*[[Ampicillin]] 50mg/kg IV q6hrs '''PLUS'''
	*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs		*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs
			**Per AAP, [[ceftazidime]] 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups<ref>https://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1</ref>
	*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]		*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]
	*Consider [[acyclovir]] for [[HSV]]		*Consider [[acyclovir]] for [[HSV]]

Rossdonaldson1 at 02:07, 3 June 2016

2016-06-03T02:07:36Z

← Revisión anterior		Revisión del 02:07 3 jun 2016
Línea 3:		Línea 3:
	*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs		*[[Cefotaxime]] 50mg/kg IV q6hrs '''OR''' [[Gentamicin]] 2.5mg/kg IV q8hrs
	*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]		*If suspecting [[S. pneumoniae]] or [[MRSA]], add [[Vancomycin]]
			*Consider [[acyclovir]] for [[HSV]]

Rossdonaldson1: Created page with "''MRSA is uncommon in the neonate Ampicillin 50mg/kg IV q6hrs '''PLUS''' Cefotaxime 50mg/kg IV q6hrs '''OR''' Gentamicin 2.5mg/kg IV q8hrs *If suspecting S. p..."

2015-05-25T19:17:21Z

Created page with "''MRSA is uncommon in the neonate *Ampicillin 50mg/kg IV q6hrs '''PLUS''' *Cefotaxime 50mg/kg IV q6hrs '''OR''' Gentamicin 2.5mg/kg IV q8hrs *If suspecting S. p..."

Página nueva